Table 1 Patient characteristics
No. of patients (%) | |
|---|---|
Age | median, 47 |
Clinical FIGO stage | |
IA2 | 1 (1.0) |
IB1 | 71 (72.5) |
IB2 | 24 (24.5) |
IIA | 2 (2.0) |
Histology | |
Squamous cell carcinoma | 74 (75.5) |
non-squamous cell carcinoma | 24 (24.5) |
SCC Ag | |
≤ 2 ng/ml | 50 (51.0) |
> 2 ng/ml | 46 (47.0) |
unknown | 2 (2.0) |
Tumor size | |
≤ 4 cm | 50 (51.0) |
> 4 cm | 42 (42.9) |
unknown | 6 (6.1) |
Deep stromal invasion | |
absent | 23 (23.5) |
present | 75 (76.5) |
Lymphovascular space invasion | |
absent | 4 (4.1) |
present | 92 (93.9) |
unknown | 2 (2.0) |
Parametrial invasion | |
negative | 84 (85.7) |
positive | 14 (14.3) |
Resection margin | |
negative | 56 (57.1) |
close (<5 mm) | 9 (9.2) |
positive | 33 (33.7) |
Pelvic lymph node metastasis | |
negative | 19 (19.4) |
positive | 79 (80.6) |
LNR | |
< 0.25 | 87 (88.8) |
≥ 0.25 | 11 (10.2) |
No. of high risk factor | |
1 | 66 (67.3) |
2 | 27 (27.6) |
3 | 5 (5.1) |